Should the health community promote smokeless tobacco (snus): comments from British American Tobacco
- PMID: 17973570
- PMCID: PMC2043003
- DOI: 10.1371/journal.pmed.0040300
Should the health community promote smokeless tobacco (snus): comments from British American Tobacco
Conflict of interest statement
Comment on
-
Should the health community promote smokeless tobacco (snus) as a harm reduction measure?PLoS Med. 2007 Jul;4(7):e185. doi: 10.1371/journal.pmed.0040185. PLoS Med. 2007. PMID: 17608560 Free PMC article.
References
-
- Gartner CE, Hall WD, Chapman S, Freeman B. Should the health community promote smokeless tobacco (snus) as a harm reduction measure? PLoS Med. 2007;4:e185. doi: 10.1371/journal.pmed.0040185. - DOI - PMC - PubMed
-
- Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino G, et al. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: Estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev. 2004;13:2035–2042. - PubMed
-
- Scientific Committee on Emerging and Newly Identified Health Risks. Health effects of smokeless tobacco products: Preliminary report. 2007. Available: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_.... Accessed 1 October 2007.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical